Emerging Infectious Diseases (Apr 2018)

Influenza A(H7N9) Virus Antibody Responses in Survivors 1 Year after Infection, China, 2017

  • Mai-Juan Ma,
  • Cheng Liu,
  • Meng-Na Wu,
  • Teng Zhao,
  • Guo-Lin Wang,
  • Yang Yang,
  • Hong-Jing Gu,
  • Peng-Wei Cui,
  • Yuan-Yuan Pang,
  • Ya-Yun Tan,
  • Hui Hang,
  • Bao Lin,
  • Jiang-Chun Qin,
  • Li-Qun Fang,
  • Wu-Chun Cao,
  • Li-Ling Cheng

DOI
https://doi.org/10.3201/eid2404.171995
Journal volume & issue
Vol. 24, no. 4
pp. 663 – 672

Abstract

Read online

Avian influenza A(H7N9) virus has caused 5 epidemic waves in China since its emergence in 2013. We investigated the dynamic changes of antibody response to this virus over 1 year postinfection in 25 patients in Suzhou City, Jiangsu Province, China, who had laboratory-confirmed infections during the fifth epidemic wave, October 1, 2016–February 14, 2017. Most survivors had relatively robust antibody responses that decreased but remained detectable at 1 year. Antibody response was variable; several survivors had low or undetectable antibody titers. Hemagglutination inhibition titer was >1:40 for <40% of the survivors. Measured in vitro in infected mice, hemagglutination inhibition titer predicted serum protective ability. Our findings provide a helpful serologic guideline for identifying subclinical infections and for developing effective vaccines and therapeutics to counter H7N9 virus infections.

Keywords